Yahoo
NasdaqGS - Nasdaq Real Time Price USD

BlossomHill Therapeutics, Inc. (BLSM)

13.75 -1.46 (-9.60%)
At close: October 30 at 4:00:01 PM EDT
13.75 0.00 (0.00%)
After hours: October 30 at 5:01:38 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
Total Revenue
0
0
0
Operating Expense
85,244
64,024
36,401
Operating Income
-85,244
-64,024
-36,401
Net Non Operating Interest Income Expense
3,662
3,480
5,706
Other Income Expense
--
-11
--
Pretax Income
-81,599
-60,555
-30,695
Net Income Common Stockholders
-81,599
-60,555
-30,695
Diluted NI Available to Com Stockholders
-81,599
-60,555
-30,695
Basic EPS
-2.66
-3.69
-1.47
Diluted EPS
-2.66
-3.69
-1.47
Basic Average Shares
29,081.16
16,405.14
20,839.07
Diluted Average Shares
29,081.16
16,405.14
30,643.66
Total Operating Income as Reported
-85,244
-64,024
-36,401
Total Expenses
85,244
64,024
36,401
Net Income from Continuing & Discontinued Operation
-81,599
-60,555
-30,695
Normalized Income
-81,599
-60,555
-30,695
Interest Income
3,662
3,480
5,706
Net Interest Income
3,662
3,480
5,706
EBIT
-85,244
-64,024
-36,401
EBITDA
-84,740
-63,583
-36,051
Reconciled Depreciation
504
441
350
Net Income from Continuing Operation Net Minority Interest
-81,599
-60,555
-30,695
Normalized EBITDA
-84,740
-63,583
-36,051
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2024 - 8/7/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: